Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06398262
Other study ID # Alar SpO2 sensor Pilot study
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 18, 2024
Est. completion date December 30, 2024

Study information

Verified date May 2024
Source Philips Clinical & Medical Affairs Global
Contact Leonie van den Heuvel, Msc.
Phone 0031639821348
Email leonie.van.den.heuvel@philips.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

BACKGROUND: As the normal functioning of the body is dependent on oxygen, low blood oxygenation is a acute problem that needs immediate attention. Measurement of blood oxygenation is therefore central to monitor patients and is usually done using light technology with a clip on the finger. Philips manufactures a measuring clip that is designed to measure oxygenation in the nasal wing instead of the finger. The advantage of this is that the nose is not affected as much as the fingers by poor blood flow in the skin, for example caused by cold. The nose is also closer to the heart and lungs than the hand, so changes in oxygenation may be detected earlier. This newer meter is an approved CE-marked product that is available for clinical use, but the next step is to investigate it systematically during and after surgery.


Description:

METHODS: The study intends to include patients undergoing planned major surgery at the surgery department at Karolinska University Hospital Huddinge. Before surgery, patients will be asked and written informed consent for participation will be obtained. Within the framework of the study, measurement with the newer measurement method on the nose is planned to be done at the same time as standard measurement on the finger is performed. The research study and oxygen saturation measurement with the nasal clamp starts when the patient enters the operating room and continues until he or she leaving the post-operative ward the day after surgery, or at the latest 24 hours after the start of the operation. Apart from the use of two body oxygenation monitors, there is no impact on the treatment and care are not affected at all. Decisions and actions based on possible changes in oxygenation will be based primarily on the traditional measurement point in the finger. After completion of the study, all anesthesia nurses and all nurses from the surgical and postoperative department in Huddinge who have worked with the Alar SpO2 (saturation) sensor during the study will be invited to participate in a semi-structured interview. All nurses who express interest in participating will receive an information sheet and consent will be signed personally with the signed personally with the interviewer before the interview starts. The investigators will collect data on staff opinions regarding the use of the Alar SpO2 sensor (such as: the differences between the Alar SpO2 sensor and the finger SpO2 sensor, the advantages and disadvantages of the Alar SpO2 sensor, advantages of using dual oximetry, and potential expansion of the work with the Alar SpO2 sensor).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date December 30, 2024
Est. primary completion date September 22, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 or older - Standard of care for planned abdominal surgery foresees continuous SpO2 monitoring intra- and post-operatively - Standard of care for planned abdominal surgery foresees arterial catheterization in order to aspirate blood for blood gas analysis - Expected overnight stay in the peri-operative unit - Able to speak and understand Swedish - Willing and able to provide written informed consent Exclusion Criteria: - Body weight below 50 kg - Procedures and/or conditions affecting the face or hands that might prevent placement of sensors - Injury/wounds or physical malformation of sensor application sites (i.e. nose, fingers) - Severe contact allergies to standard adhesives, latex or other materials found in pulse oximetry sensors (self-reported) - Nail fungus on application site - Refusal to remove artificial nails or nail polish - Severe dermatitis or hyperkeratosis (e.g. ichthyosis) at sensor application site - Raynaud's disease - Hemoglobinopathy - Expected post operative ward stay =12 hrs - Dye injections within 48 hours - Pregnant or lactating during the study period - Nasal intubation - Patient is participating in another medical device study.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Philips Clinical & Medical Affairs Global Karolinska University Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of monitoring time with a perfusion indicator >0.3% for each of the two SpO2 sensors sufficient to reliably detect desaturations of both SpO2 sensors Percentage of monitoring time with a perfusion indicator >0.3% for each Through study completion, estimated within 6 months
Primary Paired sensitivity sensitivity of the Alar SpO2 sensor vs. sensitivity of the finger SpO2 sensor Through study completion, estimated within 6 months
Primary Average time difference in desaturation detection between the Alar SpO2 sensor and the finger SpO2 sensor calculated from desaturation onset and nadir Through study completion, estimated within 6 months
Secondary Performance of both SpO2 sensors in comparison to a CO-oximetry Performance will be measured bu calculating Bias, Precision, Accuracy, root mean square error (ARMS), Intra-/inter-subject variability and Limits of agreement Through study completion, estimated within 6 months
Secondary Detection of desaturation events Percentage of desaturation events detected by both SpO2 sensors Through study completion, estimated within 6 months
Secondary Number of technical alarms for both SpO2 sensors. Number of technical alarms for both SpO2 sensors. Through study completion, estimated within 6 months
Secondary Staff experience and satisfaction System Usability Scale (SUS). The system usability scale (SUS) is a simple, ten-item attitude Likert scale giving a global view of subjective assessments of usability. Participants can score every item from 1 (strongly disagree) to 5 (strongly agree). The higher they score, the more they like the system/device. Through study completion, estimated within 6 months
Secondary Staff experience and satisfaction score for the Alar SpO2 sensorQualitative evaluation of nurse experience via semi-structured interviews Through study completion, estimated within 6 months
See also
  Status Clinical Trial Phase
Completed NCT03450746 - Metabolic and Physiological Changes During Minor Orthopaedic Surgery in Otherwise Healthy Patients
Not yet recruiting NCT04597723 - The Effect of Oxygen Given to Patients in the Postoperative Period on Nausea and Vomiting Phase 3
Terminated NCT03092297 - Insufficient Cellular Oxygen in ICU Patients With Anaemia
Recruiting NCT05780671 - Oxygen in Migraine Treatment
Completed NCT02794532 - PreOxygenation In RSI Anesthesia N/A
Completed NCT01268462 - Use of Heliox Associated With PEEP in Patients With Asthma N/A
Completed NCT05746949 - Comparison of the Effects of High-flow Nasal Cannula Oxygen and Jet Ventilation Techniques N/A
Completed NCT03842722 - Insufficient Oxygenation in Septic Patients
Completed NCT05291117 - THRIVE Ventilation for Operative Hysteroscopy Under General Anesthesia
Completed NCT02999958 - Adding Antioxidants Into Human Sequential Culture Media System N/A
Completed NCT03030781 - Relationship of Cricoid With the Right and Left Bronchial Diameters in the Pediatric Population Using Three-dimensional Imaging. N/A
Not yet recruiting NCT06372106 - Project Mountain - Comparing SpO2 and SaO2 for Accuracy